Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration
Year: 2006
Type: article
Study design: Clinical Trial
Source: Ophthalmology
Institutions: University of Miami, Ophthalmic Consultants of Boston, Genentech
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Genentech
OpenAlex ID: W2081273617
